You are viewing an old version of this page. View the current version.
Compare with Current
View Page History
« Previous
Version 26
Next »
Term | description type | Language/acceptability | Language/acceptability | Case significance |
---|
Product containing precisely [substance][number][Unit of measure ]/[1] each [dose form] (clinical drug) | FSN | us:P | gb:P | ci |
[substance] [Unit of measure ] [dose form] | SYN | us:P | gb:P | ci |
Attribute cardinality | Attribute | Value | role group number | role group cardinality |
---|
|
| | 0 | N/A |
1..1 | | | 0 | 1..1 |
1..1 | | | 0 | 1..1 |
1..1 | | | 0 | 1..1 |
0..1 | | | 0 | 0..1 |
0..1 | | | 0 | 0..1 |
1..1 | | | 1..* | 1..* |
1..1 | | | 1..* |
1..1 | | | 1..* |
1..1 | | | 1..* |
1..1 | | | 1..* |
1..1 | | | 1..* |
900000000000073002 |Defined (core metadata concept)|
- Apply General rules for generating descriptions for templates
- Exceptions:Concepts with product strength that is "not equal to" (e.g. with product strength expressed as a range, greater than, or less than) will have definition status 900000000000074008| Primitive (core metadata concept) and will have the appropriate Medicinal Product Form-only (MPF-only) concept as a stated parent.
- For multiple ingredients, the ingredients in each description need to be in alphabetical order e.g. Codeine and paracetamol for FSN but Acetaminophen and codeine (for US PT).
DRUGS-276
-
Getting issue details...
STATUS